The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement control protein-CR2 chimeras

A.A. Johnson, A.M. Rosengard, K. Skjødt, J.M. Ahearn, R.G.Q. Leslie

Research output: Contribution to journalJournal articleResearch

Original languageEnglish
JournalEuropean Journal of Immunology
Pages (from-to)3837-3844
Publication statusPublished - 1999

Cite this